Bai Y - Search Results

1

Ischemic stroke risk in East Asian patients with CHA₂DS₂-VASc score of 1: systematic review and meta-analysis.

Bai Y, Shantsila A, Lip GY. Bai Y, et al. Expert Rev Cardiovasc Ther. 2017 Feb;15(2):145-150. doi: 10.1080/14779072.2017.1281742. Epub 2017 Jan 20. Expert Rev Cardiovasc Ther. 2017. PMID: 28076988 Review.

2

Differences in Quality of Life Between Atrial Fibrillation Patients with Low Stroke Risk Treated With and Without Catheter Ablation.

Bai Y, Bai R, Wu JH, Zhang T, Liu N, Shi XB, Liu XY, Liu XH, Du X, Dong JZ, Ma CS. Bai Y, et al. Among authors: bai r. J Am Heart Assoc. 2015 Sep 16;4(9):e002130. doi: 10.1161/JAHA.115.002130. J Am Heart Assoc. 2015. PMID: 26376990 Free PMC article.

3

Safety of antithrombotic drugs in patients with atrial fibrillation and non-end-stage chronic kidney disease: Meta-analysis and systematic review.

Bai Y, Chen H, Yang Y, Li L, Liu XY, Shi XB, Ma CS. Bai Y, et al. Thromb Res. 2016 Jan;137:46-52. doi: 10.1016/j.thromres.2015.11.020. Epub 2015 Nov 21. Thromb Res. 2016. PMID: 26610746 Review.

4

Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis.

Bai Y, Deng H, Shantsila A, Lip GY. Bai Y, et al. Stroke. 2017 Apr;48(4):970-976. doi: 10.1161/STROKEAHA.116.016275. Epub 2017 Feb 17. Stroke. 2017. PMID: 28213573 Review.

5

The Global Burden of Atrial Fibrillation and Stroke: A Systematic Review of the Clinical Epidemiology of Atrial Fibrillation in Asia.

Bai Y, Wang YL, Shantsila A, Lip GYH. Bai Y, et al. Chest. 2017 Oct;152(4):810-820. doi: 10.1016/j.chest.2017.03.048. Epub 2017 Apr 17. Chest. 2017. PMID: 28427968 Review.

6

Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".

Bai Y, Shantsila A, Lip GYH. Bai Y, et al. Stroke. 2017 Jun;48(6):e149. doi: 10.1161/STROKEAHA.117.017460. Epub 2017 Apr 28. Stroke. 2017. PMID: 28455316 No abstract available.

7

Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review.

Deng H, Bai Y, Shantsila A, Fauchier L, Potpara TS, Lip GYH. Deng H, et al. Among authors: bai y. Clin Res Cardiol. 2017 Oct;106(10):813-823. doi: 10.1007/s00392-017-1123-0. Epub 2017 May 30. Clin Res Cardiol. 2017. PMID: 28560516 Free PMC article. Review.

8

Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban.

Bai Y, Shi XB, Ma CS, Lip GYH. Bai Y, et al. Am J Cardiol. 2017 Nov 1;120(9):1689-1695. doi: 10.1016/j.amjcard.2017.07.072. Epub 2017 Aug 1. Am J Cardiol. 2017. PMID: 28844510 Free article. Review.

9

Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis.

Bai Y, Guo SD, Deng H, Shantsila A, Fauchier L, Ma CS, Lip GYH. Bai Y, et al. Age Ageing. 2018 Jan 1;47(1):9-17. doi: 10.1093/ageing/afx103. Age Ageing. 2018. PMID: 28985259 Review.

10

Modelling projections for the risks related with atrial fibrillation in East Asia: a focus on ischaemic stroke and death.

Bai Y, Guo SD, Shantsila A, Lip GYH. Bai Y, et al. Europace. 2018 Oct 1;20(10):1584-1590. doi: 10.1093/europace/eux328. Europace. 2018. PMID: 29165583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,103 results

Search Page

Filters